Qiming Venture Partners, founded in 2006, is a venture capital firm that invests in young, fast-growing companies in the TMT and healthcare sectors. The firm is an early to growth stage venture capital firm with offices in Shanghai, Beijing, Suzhou, ...Show all
Phone: +86 21 6101 6522
Room 3901, Jinmao Tower
88 Century Boulevard
Shanghai, 200121
Shanghai, China
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2021-01-20 | Irvine Technology | Series E | $100M | Lingfeng Capital, New Oriental Education & Technology, and Prospect Avenue Capital |
2021-01-18 | Yunji Technology | Series C | $77.01M | AlphaX Partners, CITIC Securities, LanTing Capital, Lenovo Capital and Incubator Group, and Tencent Holdings |
2021-01-14 | WeRide | Series B - II | $110M | CDB Venture Capital, CDB-RW Funds, CMC Capital Partners, Fosun RZ Capital, Hengjian Holdings, Huajin Capital, Sinovation Ventures, Tryin Capital, and Yutong |
2021-01-07 | Kira Pharmaceuticals | Series B - III | $53.5M | Foresite Capital, Quan Capital, RA Capital Management, Shenwan Capital, and Vivo Capital |
2020-12-31 | Insight Lifetech | Series C | SDIC, Sequoia Capital China, and TigerYeah Capital |